Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M175Revenue $M5.7Net Margin (%)-817.7Altman Z-Score-15.7
Enterprise Value $M143EPS $-0.8Operating Margin %-976.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.1Pre-tax Margin (%)-817.7Higher ROA y-yY
Price/Book10.410-y EBITDA Growth Rate %-38.0Quick Ratio2.6Cash flow > EarningsN
Price/Sales33.65-y EBITDA Growth Rate %-21.9Current Ratio2.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-71.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-247.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.0ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSFirst Eagle Investment 2015-03-31 Reduce-0.01%$2.1 - $2.83
($2.4)
$ 2.400%Reduce 58.43%587,976
SNSSFirst Eagle Investment 2014-12-31 Buy 0.01%$1.05 - $6.64
($2.06)
$ 2.4017%New holding1,414,276
SNSSFirst Eagle Investment 2014-09-30 Sold Out $5.553 - $8.23
($6.91)
$ 2.40-65%Sold Out0
SNSSFirst Eagle Investment 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 2.40-53%New holding200,000
SNSSFirst Eagle Investment 2013-03-31 Sold Out -0.01%$4 - $6.49
($5.21)
$ 2.40-54%Sold Out0
SNSSFirst Eagle Investment 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 2.40-32%Reduce 30.24%350,000
SNSSFirst Eagle Investment 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 2.40-14%New holding501,727
SNSSFirst Eagle Investment 2009-12-31 Sold Out $1.8 - $12.54
($3.76)
$ 2.40-36%Sold Out0
SNSSFirst Eagle Investment 2009-06-30 Reduce$0.99 - $3.45
($1.95)
$ 2.4023%Reduce 90.60%16,667
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BARRIS PETER J10% Owner 2014-08-29Sell266,700$7.97-69.89view
BARRETT M JAMES10% Owner 2014-08-29Sell266,700$7.97-69.89view
Growth Equity Opportunities Fu10% Owner 2014-08-29Sell266,700$7.97-69.89view
SANDELL SCOTT D10% Owner 2014-08-29Sell266,700$7.97-69.89view
KOLLURI KRISHNA KITTU10% Owner 2014-08-29Sell266,700$7.97-69.89view
KERINS PATRICK J10% Owner 2014-08-29Sell266,700$7.97-69.89view
DRANT RYAN D10% Owner 2014-08-29Sell266,700$7.97-69.89view
BASKETT FOREST10% Owner 2014-08-29Sell266,700$7.97-69.89view
BAY CITY CAPITAL LLC10% Owner 2014-08-28Sell300,700$7.98-69.92view
Misfeldt DaytonDirector, 10% Owner 2014-08-28Sell300,700$7.98-69.92view

Press Releases about SNSS :

    Quarterly/Annual Reports about SNSS:

    News about SNSS:

    Articles On GuruFocus.com
    ciazek stock Mar 28 2015 
    comment on SNSS Mar 02 2013 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
    Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
    cooldecency99 note on SNSS May 01 2010 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
    Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
    Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 

    More From Other Websites
    Sunesis Pharmaceuticals Announces Presentations of VALOR Data at the 20th Congress of the European... May 21 2015
    Sunesis Pharmaceuticals Announces Presentations of VALOR Data at the 20th Congress of the European... May 21 2015
    The Life Sciences Report Releases 2015 Small-Cap Biotech Watchlist Update May 15 2015
    Sunesis Pharmaceuticals Announces Presentation of VALOR Data at the 2015 ASCO Annual Meeting May 14 2015
    Sunesis Pharmaceuticals Announces Presentation of VALOR Data at the 2015 ASCO Annual Meeting May 14 2015
    Sunesis to Present at the 2015 UBS Global Health Care Conference May 13 2015
    Sunesis to Present at the 2015 UBS Global Health Care Conference May 13 2015
    10-Q for Sunesis Pharmaceuticals, Inc. May 07 2015
    10-K for Sunesis Pharmaceuticals, Inc. May 06 2015
    Sunesis Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today May 05 2015
    Sunesis reports 1Q loss May 05 2015
    Sunesis reports 1Q loss May 05 2015
    SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2015
    Sunesis Pharmaceuticals Reports First Quarter 2015 Financial Results and Recent Highlights May 05 2015
    Q1 2015 Sunesis Pharmaceuticals Inc Earnings Release - Time Not Supplied May 05 2015
    Sunesis Pharmaceuticals Reports First Quarter 2015 Financial Results and Recent Highlights May 05 2015
    Sunesis to Host Conference Call on May 5th to Discuss First Quarter 2015 Financial Results and... Apr 28 2015
    Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind Apr 10 2015
    Sunesis Pharmaceuticals Inc.'s CEO Daniel Swisher Interviewed by The Life Sciences Report Apr 02 2015
    Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed’s... Mar 31 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK